BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 1389488)

  • 1. Prognostic significance of pretreatment serum levels of squamous cell carcinoma antigen and CA 125 in cervical carcinoma.
    Avall-Lundqvist EH; Sjövall K; Nilsson BR; Eneroth PH
    Eur J Cancer; 1992; 28A(10):1695-702. PubMed ID: 1389488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix.
    Takeda M; Sakuragi N; Okamoto K; Todo Y; Minobe S; Nomura E; Negishi H; Oikawa M; Yamamoto R; Fujimoto S
    Acta Obstet Gynecol Scand; 2002 May; 81(5):451-7. PubMed ID: 12027820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer.
    Gaarenstroom KN; Bonfrer JM; Kenter GG; Korse CM; Hart AA; Trimbos JB; Helmerhorst TJ
    Cancer; 1995 Sep; 76(5):807-13. PubMed ID: 8625184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM; Groenier KH; de Bruijn HW; Hollema H; ten Hoor KA; van der Zee AG; Aalders JG
    J Clin Oncol; 1996 Jan; 14(1):111-8. PubMed ID: 8558185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D; Xu XX; Yan DD; Yuan SH; Lou HM
    Zhonghua Zhong Liu Za Zhi; 2019 May; 41(5):357-362. PubMed ID: 31137169
    [No Abstract]   [Full Text] [Related]  

  • 6. The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy.
    Hong JH; Tsai CS; Chang JT; Wang CC; Lai CH; Lee SP; Tseng CJ; Chang TC; Tang SG
    Int J Radiat Oncol Biol Phys; 1998 Jul; 41(4):823-30. PubMed ID: 9652844
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
    Gaarenstroom KN; Kenter GG; Bonfrer JM; Korse CM; Van de Vijver MJ; Fleuren GJ; Trimbos JB
    Gynecol Oncol; 2000 Apr; 77(1):164-70. PubMed ID: 10739706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of squamous cell carcinoma antigen in cancer of the human uterine cervix. Comparison with CEA and CA-125.
    Verlooy H; Devos P; Janssens J; Mortelmans L; Gerits M; Bonte J; De Roo M
    Gynecol Obstet Invest; 1991; 32(1):55-8. PubMed ID: 1765320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumour markers and their prognostic value in adenocarcinoma of the cervix.
    Ngan HY; Cheung AN; Lauder IJ; Cheng DK; Wong LC; Ma HK
    Tumour Biol; 1998; 19(6):439-44. PubMed ID: 9817971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implications of elevated pretreatment carcinoembryonic antigen in patients with advanced squamous cell carcinoma of the uterine cervix.
    Chen SW; Liang JA; Hung YC; Yeh LS; Chang WC; Yang SN; Lin FJ
    Tumour Biol; 2008; 29(4):255-61. PubMed ID: 18781097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical values of squamous cell carcinoma antigen and carcinoembryonic antigen in patients with cervical cancer treated with concurrent chemoradiotherapy.
    Yoon SM; Shin KH; Kim JY; Seo SS; Park SY; Kang S; Cho KH
    Int J Gynecol Cancer; 2007; 17(4):872-8. PubMed ID: 17343571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum levels of squamous cell carcinoma antigen and ovarian carcinoma antigen (CA 125) in patients with benign and malignant diseases of the uterine cervix.
    Gocze PM; Vahrson HW; Freeman DA
    Oncology; 1994; 51(5):430-4. PubMed ID: 8052484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen.
    Bonfrer JM; Gaarenstroom KN; Korse CM; Van Bunningen BN; Kenemans P
    Anticancer Res; 1997; 17(3C):2329-34. PubMed ID: 9245246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
    Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.
    Ikeda S; Yoshimura K; Onda T; Kasamatsu T; Kato T; Ishikawa M; Sasajima Y; Tsuda H
    J Obstet Gynaecol Res; 2012 Oct; 38(10):1260-5. PubMed ID: 22563932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of serum squamous cell carcinoma antigen levels in predicting chemosensitivity, lymph node metastasis, and prognosis in patients with cervical squamous cell carcinoma.
    Chen P; Jiao L; Ren F; Wang DB
    BMC Cancer; 2020 May; 20(1):423. PubMed ID: 32410650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Both TPA and SCC-Ag levels are prognostic even in high-risk stage Ib-IIa cervical carcinoma as determined by a stratification analysis.
    Yuan CC; Wang PH; Ng HT; Tsai LC; Juang CM; Chiu LM
    Eur J Gynaecol Oncol; 2002; 23(1):17-20. PubMed ID: 11876385
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum tumour markers in carcinoma of the uterine cervix and outcome following radiotherapy.
    Sproston AR; Roberts SA; Davidson SE; Hunter RD; West CM
    Br J Cancer; 1995 Dec; 72(6):1536-40. PubMed ID: 8519673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenocarcinoma of the uterine cervix. Prognostic significance of pretreatment serum CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen levels in relation to clinical and histopathologic tumor characteristics.
    Duk JM; De Bruijn HW; Groenier KH; Fleuren GJ; Aalders JG
    Cancer; 1990 Apr; 65(8):1830-7. PubMed ID: 2317761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improvement of clinical staging in cervical cancer with serum squamous cell carcinoma antigen and CA 125 determinations.
    Massuger LF; Koper NP; Thomas CM; Dom KE; Schijf CP
    Gynecol Oncol; 1997 Mar; 64(3):473-6. PubMed ID: 9062153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.